학술논문
End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).
Document Type
Journal
Author
Shah, Bijal D.; Bishop, Michael Russell; Oluwole, Olalekan O.; Logan, Aaron; Baer, Maria R.; Donnellan, William Bruce; Carr-O'Dwyer, Kristen Marie; Holmes, Houston; Arellano, Martha Lucia; Ghobadi, Armin; Pagel, John M.; Lin, Yi; Cassaday, Ryan Daniel; Park, Jae Hong; Mardiros, Armen; Shen, Tong; Goyal, Lovely; Vezan, Remus; Jain, Rajul K.; Wierda, William G.
Source
Subject
Language
English
ISSN
15277755